C.E.Management Integrated LaboratoryLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

C.E.Management Integrated LaboratoryLtd heeft een totaal eigen vermogen van ¥4.7B en een totale schuld van ¥603.0M, wat de schuld-eigenvermogensverhouding op 12.7% brengt. De totale activa en totale passiva bedragen respectievelijk ¥6.9B en ¥2.2B. De EBIT C.E.Management Integrated LaboratoryLtd is ¥451.0M waardoor de rentedekking -22.6 is. Het heeft contanten en kortetermijnbeleggingen van ¥2.6B.

Belangrijke informatie

12.7%

Verhouding schuld/eigen vermogen

JP¥603.00m

Schuld

Rente dekkingsratio	-22.6x
Contant	JP¥2.59b
Aandelen	JP¥4.73b
Totaal verplichtingen	JP¥2.20b
Totaal activa	JP¥6.93b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

C.E.Management Integrated LaboratoryLtd's (TSE:6171) Dividend Will Be ¥6.00

Oct 14

C.E.Management Integrated LaboratoryLtd (TSE:6171) Is Due To Pay A Dividend Of ¥6.00

Sep 29

C.E.Management Integrated LaboratoryLtd (TSE:6171) Will Pay A Dividend Of ¥6.00

Aug 27

We Think You Can Look Beyond C.E.Management Integrated LaboratoryLtd's (TSE:6171) Lackluster Earnings

Mar 30

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥4.0B ) 6171 } overtreffen de korte termijn passiva ( ¥1.3B ).

Langlopende schulden: De kortetermijnactiva 6171 ( ¥4.0B ) overtreffen de langetermijnschulden ( ¥922.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 6171 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 6171 is de afgelopen 5 jaar gestegen van 0% naar 12.7%.

Schuldendekking: De schuld van 6171 wordt goed gedekt door de operationele kasstroom ( 117.9% ).

Rentedekking: 6171 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

C.E.Management Integrated LaboratoryLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

C.E.Management Integrated LaboratoryLtd's (TSE:6171) Dividend Will Be ¥6.00

C.E.Management Integrated LaboratoryLtd (TSE:6171) Is Due To Pay A Dividend Of ¥6.00

C.E.Management Integrated Laboratory Co.Ltd to Report Q3, 2024 Results on Nov 13, 2024

C.E.Management Integrated LaboratoryLtd (TSE:6171) Will Pay A Dividend Of ¥6.00

C.E.Management Integrated Laboratory Co.Ltd Announces Dividend for the Second Quarter End and Provides Fiscal year Ending December 31, 2024

C.E.Management Integrated Laboratory Co.Ltd Announces Dividend for the Second Quarter End and Provides Fiscal year Ending December 31, 2024

Second quarter 2024 earnings released: EPS: JP¥3.38 (vs JP¥3.59 in 2Q 2023)

Dividend of JP¥6.00 announced

C.E.Management Integrated Laboratory Co.Ltd to Report Q2, 2024 Results on Aug 08, 2024

First quarter 2024 earnings released: EPS: JP¥6.69 (vs JP¥7.11 in 1Q 2023)

Final dividend of JP¥6.00 announced

C.E.Management Integrated Laboratory Co.Ltd to Report Q1, 2024 Results on May 09, 2024

We Think You Can Look Beyond C.E.Management Integrated LaboratoryLtd's (TSE:6171) Lackluster Earnings

Full year 2023 earnings released: EPS: JP¥13.38 (vs JP¥24.56 in FY 2022)

Full year 2023 earnings released: EPS: JP¥13.38 (vs JP¥24.56 in FY 2022)

C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 22, 2024

Upcoming dividend of JP¥6.00 per share at 3.7% yield

C.E.Management Integrated Laboratory Co.Ltd to Report Fiscal Year 2023 Results on Feb 09, 2024

C.E.Management Integrated Laboratory Co.Ltd Provides Dividend Guidance for the Year Ending December 31, 2023

Third quarter 2023 earnings released: JP¥1.90 loss per share (vs JP¥1.62 loss in 3Q 2022)

C.E. Management Integrated Laboratory Co. Ltd Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2023

Second quarter 2023 earnings released: EPS: JP¥3.59 (vs JP¥3.87 in 2Q 2022)

Upcoming dividend of JP¥6.00 per share at 3.5% yield

First quarter 2023 earnings released: EPS: JP¥7.11 (vs JP¥6.19 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥24.56 (vs JP¥14.86 in FY 2021)

Full year 2022 earnings released: EPS: JP¥24.56 (vs JP¥14.86 in FY 2021)

C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 23, 2023

C.E.Management Integrated Laboratory Co.Ltd to Report Fiscal Year 2022 Results on Feb 10, 2023

Upcoming dividend of JP¥5.50 per share

Less than half of directors are independent

Third quarter 2022 earnings released: JP¥1.62 loss per share (vs JP¥0.84 loss in 3Q 2021)

C.E.Management Integrated Laboratory Co.Ltd to Report Q3, 2022 Results on Nov 10, 2022

Second quarter 2022 earnings released: EPS: JP¥3.87 (vs JP¥7.96 in 2Q 2021)

C.E.Management Integrated Laboratory Co.Ltd to Report Q2, 2022 Results on Aug 10, 2022

Upcoming dividend of JP¥5.50 per share

First quarter 2022 earnings released: EPS: JP¥6.19 (vs JP¥3.77 in 1Q 2021)

Less than half of directors are independent

C.E.Management Integrated Laboratory Co.Ltd to Report Q1, 2022 Results on May 13, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 23, 2022

Upcoming dividend of JP¥5.00 per share

Third quarter 2021 earnings released: JP¥0.84 loss per share (vs JP¥1.37 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥7.96 (vs JP¥4.28 in 2Q 2020)

Upcoming dividend of JP¥4.50 per share

C.E.Management Integrated Laboratory Co.Ltd (TSE:6171) announces an Equity Buyback for 360,000 shares, representing 2.47% for ¥180 million.

C.E.Management Integrated Laboratory Co.Ltd to Report Q1, 2021 Results on May 13, 2021

Full year 2020 earnings released: EPS JP¥20.18 (vs JP¥21.13 in FY 2019)

C.E.Management Integrated Laboratory Co.Ltd (TSE:6171) agreed to acquire Advanced Knowledge Laboratory Inc. from Kaoru Ikejima for ¥880 million.

New 90-day low: JP¥329

New 90-day low: JP¥357

C.E.Management Integrated Laboratory Co.Ltd to Report Fiscal Year 2020 Results on Feb 12, 2021

C.E.Management Integrated Laboratory Co.Ltd (TSE:6171) acquired Okinawa Design Center Co., Ltd. from Shigeyasu Matsuda.

C.E.Management Integrated Laboratory Co.Ltd to Report Q3, 2020 Results on Nov 12, 2020

C.E.Management Integrated Laboratory Co.Ltd to Report Q2, 2020 Results on Aug 13, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven